These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir. Seyfoddin A; Al-Kassas R Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312 [TBL] [Abstract][Full Text] [Related]
65. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa. Makhlof A; Werle M; Tozuka Y; Takeuchi H J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935 [TBL] [Abstract][Full Text] [Related]
66. Methotrexate-loaded SLNs prepared by coacervation technique: in vitro cytotoxicity and in vivo pharmacokinetics and biodistribution. Battaglia L; Serpe L; Muntoni E; Zara G; Trotta M; Gallarate M Nanomedicine (Lond); 2011 Nov; 6(9):1561-73. PubMed ID: 22011315 [TBL] [Abstract][Full Text] [Related]
67. Vitamin-Derived Nanolipoidal Carriers for Brain Delivery of Dimethyl Fumarate: A Novel Approach with Preclinical Evidence. Kumar P; Sharma G; Kumar R; Malik R; Singh B; Katare OP; Raza K ACS Chem Neurosci; 2017 Jun; 8(6):1390-1396. PubMed ID: 28157295 [TBL] [Abstract][Full Text] [Related]
68. Delivery of sesamol-loaded solid lipid nanoparticles to the brain for menopause-related emotional and cognitive central nervous system derangements. Kakkar V; Mishra AK; Chuttani K; Chopra K; Kaur IP Rejuvenation Res; 2011 Dec; 14(6):597-604. PubMed ID: 21978086 [TBL] [Abstract][Full Text] [Related]
69. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin. Zhang N; Ping Q; Huang G; Xu W; Cheng Y; Han X Int J Pharm; 2006 Dec; 327(1-2):153-9. PubMed ID: 16935443 [TBL] [Abstract][Full Text] [Related]
70. Anti-glioma activity and the mechanism of cellular uptake of asiatic acid-loaded solid lipid nanoparticles. Garanti T; Stasik A; Burrow AJ; Alhnan MA; Wan KW Int J Pharm; 2016 Mar; 500(1-2):305-15. PubMed ID: 26775062 [TBL] [Abstract][Full Text] [Related]
71. Surface design of nanocarriers: Key to more efficient oral drug delivery systems. Spleis H; Sandmeier M; Claus V; Bernkop-Schnürch A Adv Colloid Interface Sci; 2023 Mar; 313():102848. PubMed ID: 36780780 [TBL] [Abstract][Full Text] [Related]
72. Enhanced brain targeting efficacy of Olanzapine through solid lipid nanoparticles. Natarajan J; Baskaran M; Humtsoe LC; Vadivelan R; Justin A Artif Cells Nanomed Biotechnol; 2017 Mar; 45(2):364-371. PubMed ID: 27002542 [TBL] [Abstract][Full Text] [Related]
73. Biological voyage of solid lipid nanoparticles: a proficient carrier in nanomedicine. Ali H; Singh SK Ther Deliv; 2016 Oct; 7(10):691-709. PubMed ID: 27790956 [TBL] [Abstract][Full Text] [Related]
74. Solid lipid nanoparticles surface modified with anti-Contactin-2 or anti-Neurofascin for brain-targeted delivery of medicines. Gandomi N; Varshochian R; Atyabi F; Ghahremani MH; Sharifzadeh M; Amini M; Dinarvand R Pharm Dev Technol; 2017 May; 22(3):426-435. PubMed ID: 27575893 [TBL] [Abstract][Full Text] [Related]
75. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles. Varshosaz J; Minayian M; Moazen E J Liposome Res; 2010 Jun; 20(2):115-23. PubMed ID: 19694503 [TBL] [Abstract][Full Text] [Related]
76. Bile salts enhance the intestinal absorption of lipophilic drug loaded lipid nanocarriers: mechanism and effect in rats. Zhang Z; Gao F; Jiang S; Chen L; Liu Z; Yu H; Li Y Int J Pharm; 2013 Aug; 452(1-2):374-81. PubMed ID: 23694804 [TBL] [Abstract][Full Text] [Related]
77. Vitamin B12-loaded solid lipid nanoparticles as a drug carrier in cancer therapy. Genç L; Kutlu HM; Güney G Pharm Dev Technol; 2015 May; 20(3):337-44. PubMed ID: 24344935 [TBL] [Abstract][Full Text] [Related]
78. Relationship between particle size and lung retention time of intact solid lipid nanoparticle suspensions after pulmonary delivery. Huang Z; Huang Y; Wang W; Fu F; Wang W; Dang S; Li C; Ma C; Zhang X; Zhao Z; Pan X; Wu C J Control Release; 2020 Sep; 325():206-222. PubMed ID: 32619747 [TBL] [Abstract][Full Text] [Related]
79. Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Kakkar V; Singh S; Singla D; Kaur IP Mol Nutr Food Res; 2011 Mar; 55(3):495-503. PubMed ID: 20938993 [TBL] [Abstract][Full Text] [Related]
80. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis. Pradhan M; Singh D; Singh MR Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]